Conceiving post-breast cancer: Pausing endocrine therapy is safe, study confirms
Young women with previous breast cancer can safely pause endocrine therapy for up to two years to attempt pregnancy, according to a landmark international study. …
Tag: Breast cancer
Breast cancer risk from progestogen-only contraceptives ‘on par’ with combined pill
Progestogen-only contraceptives confer a similar increased risk of breast cancer as combined oral contraceptives, according to UK and Australian researchers. Their study involving nearly 28,000…
Best comments of the week: gender dysphoria, greedy locum obstetricians and reluctant patients
Our readers are posting hundreds of comments on the AusDoc community platform. You’ve written about when patients mentally leave the consultation, the “greed” of locum obstetricians,…
Omitting radiotherapy ‘safe’ for older women with early breast cancer
Radiotherapy can be safely omitted for older women with early oestrogen receptor-positive breast cancer treated with breast-conserving surgery and tamoxifen, according to Scottish doctors. Their…
Medication reduces hot flushes in women on endocrine therapy after breast cancer: Aus study
A Monash University-led trial shows a new medication significantly reduces vasomotor symptoms in women taking oral adjuvant endocrine therapy after breast cancer. The drug, called…
Ballet helps breast cancer survivors improve shoulder mobility: study
Classical ballet classes could aid recovery from upper-body morbidity in women following breast cancer therapy, a small Australian study suggests. UNSW Sydney–led researchers say the…
Can AI reduce the harms and cost of Australia’s breast cancer screening program?
There is a debate raging within the medical community which has yet to reach the wider public about the costs and benefits of Australia’s national…
Risk of developing metastatic breast cancer ‘declines with time’
Australian women’s risk of developing metastatic breast cancer after a diagnosis of localised disease declines with time, dropping to about 1% after five years, researchers…
Digital breast tomosynthesis screening ‘ups invasive investigations’
The 3D modality finds both more malignant and more benign lesions than digital mammography, study shows.
Aromatase inhibitors ‘eclipse tamoxifen’ in younger women
Among patients with early breast cancer undergoing ovarian suppression, aromatase inhibitors cut tumour recurrence by a third, data show.
